NCT01316939

Who might be able to join this trial:

• You must have already taken part in a related induction study (Study CCX114151 or another GSK-sponsored study) and shown improvement in your Crohn's disease symptoms or reached remission during that study
• You must be willing and able to sign a consent form before any procedures in this study begin
• If you are a woman who could become pregnant, you must either not be sexually active or agree to use a reliable form of contraception that has less than a 1% chance of failing
• Any medications you are already taking for Crohn's disease must be at a stable, unchanged dose
• If you are currently taking steroid medications, you must be willing to gradually reduce your steroid dose during the study

Who may not be able to join:

• Women who are pregnant, who test positive for pregnancy, or who are breastfeeding
• People who are known or suspected to have coeliac disease, or who test positive for a related antibody — this will need to be checked with a blood test before joining (confirm with trial site)
• People who have a known or suspected blockage in the small bowel that is causing symptoms
• People who have certain types of abnormal connections or tunnels between the bowel and the skin or other nearby areas that are likely to need surgery during the study
• People who currently have a serious infection or blood poisoning that requires intravenous (drip) antibiotics for more than 2 weeks
• People who have signs of liver problems, liver disease, or a hepatitis (liver) infection

Important: Always verify eligibility with the trial site directly before applying.